Work

Lorlatinib in a Child with ALK -Fusion–Positive High-Grade Glioma

Year: 2021

Type: article

Abstract: Lorlatinib Response in ALK-Fusion–Positive Glioma A child near death with an ALK-fusion–positive high-grade glioma refractory to standard treatment had a dramatic response when treatment with lorla...

Source: New England Journal of Medicine

DOI: 10.1056/nejmc2101264

Authors: Aditi Bagchi, Brent A. Orr, Olivia Campagne, Sandeep Dhanda, Sreenath Nair, Quynh Tran, Anthony M. Christensen, Amar Gajjar, Larissa V. Furtado, Aksana Vasilyeva, Frederick Boop, Clinton Stewart, Giles W. Robinson

Institutions: St. Jude Children's Research Hospital, Le Bonheur Children's Hospital

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: American Lebanese Syrian Associated Charities, National Cancer Institute

Award: Cancer Center Support Grant (CCSG)

OpenAlex ID: W3196158772

FWCI: 6.06

Cites: 5

Cited by: 62

Related to: 10